Vident Investment Advisory, LLC Penumbra Inc Transaction History

Vident Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$187.51 - $283.98 $189,197 - $286,535	-1,009 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $2,142 - $2,592	9 Added 0.9%	1,009 $290,000
Q3 2021 Nov 12, 2021	SELL	$250.72 - $291.24 $73,962 - $85,915	-295 Reduced 22.78%	1,000 $267,000
Q2 2021 Aug 13, 2021	BUY	$235.0 - $310.7 $27,025 - $35,730	115 Added 9.75%	1,295 $355,000
Q1 2021 May 14, 2021	BUY	$175.6 - $291.43 $207,208 - $343,887	1,180 New	1,180 $319,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.